Disclaimer:

Disclaimer: The blog posts and comments on this blog and posts on social networks are not investment recommendation, are provided solely for informational purposes, and do not constitute an offer or solicitation to buy or sell any securities. The opinions expressed on the blog are Petar Posledovich's. Petar Posledovich does not guarantee the accuracy of the information presented on this blog and social networks. The information presented is "as is". The blog is stocks analysis and valuation, Bitcoin, Cryptocurrencies, Artificial Intelligence, AI, deep-learning focused. Independent, unbiased AI insights. Petar Vladimirov Posledovich is not liable for any investment losses incurred by reading and interpreting blog posts on this blog and posts on social networks. Conflicts of interest: I may possess some of the securities, currencies or their derivatives mentioned in the blog post and posts on social networks! The blog is property of Wolfteam Ltd. www.wolfteamedge.com Respectfully yours, Petar Posledovich

Monday, November 27, 2023

Illumina Valuation


Illiumina Inc., the American biotechnology company that designs and manufactures sequencing platforms and micro array scanners is undervalued, according to Wolfteam Ltd.'s revenue and profitability projections.

With revenue of 4.53 billion USD, growing at 39.73 %, net profit margin of 16.84 %, Illumina Inc's intrinsic value is 21 billion USD, compared with Illumina Inc's current market capitalization of 15.62 billion USD.

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)